| |
| |
|
| Insider
Information: |
Royston Ivor |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,040,880 |
|
|
Indirect Shares
|
12,471,560 |
|
|
| Direct
Value |
$634,648 |
|
|
|
Indirect Value
|
$14,018,512 |
|
|
| Total
Shares |
13,512,440 |
|
|
| Total
Value |
$14,653,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -29.1%
|
-58.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corautus Genetics Inc |
VEGF |
Director |
2004-05-07 |
126,963 |
2004-05-07 |
0 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2013-05-26 |
114,955 |
2015-05-20 |
11,810,558 |
Premium* |
|
|
Biocept Inc |
BIOC |
Director |
2015-11-09 |
34,878 |
2015-02-13 |
16,858 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2016-03-08 |
0 |
2017-03-20 |
625,545 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2024-02-25 |
764,084 |
2024-02-25 |
18,599 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2024-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
764,084 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
738,865 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
713,646 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
688,427 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
663,208 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
637,989 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-08-26 |
4 |
S |
$4.01 |
$53,656 |
D/D |
(13,379) |
612,770 |
0 |
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
626,149 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-05-26 |
4 |
S |
$1.90 |
$25,022 |
D/D |
(13,162) |
600,930 |
0 |
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
614,092 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-02-28 |
4 |
S |
$2.78 |
$40,678 |
D/D |
(14,635) |
588,873 |
0 |
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2022-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,219 |
603,508 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2021-12-29 |
4 |
OE |
$0.90 |
$6,300 |
D/D |
7,000 |
578,289 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & President |
• • – |
2021-11-15 |
4 |
B |
$5.56 |
$44,480 |
D/D |
8,000 |
548,599 |
2.81 |
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & PresidentOfficer |
• • – |
2021-02-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,599 |
|
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
CEO & PresidentOfficer |
• • – |
2021-02-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
540,599 |
|
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2017-03-20 |
4 |
D |
$13.75 |
$1,718,750 |
I/I |
(125,000) |
625,545 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Director |
– • – |
2016-03-08 |
4 |
A |
$0.00 |
$0 |
I/I |
600,545 |
600,545 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Director |
– • – |
2016-03-08 |
4 |
B |
$12.00 |
$1,800,000 |
I/I |
150,000 |
750,545 |
2.1 |
- |
|
| BIOC |
Biocept Inc |
Director |
– • – |
2015-11-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,285 |
34,878 |
0 |
- |
|
| BIOC |
Biocept Inc |
Director |
– • – |
2015-05-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,735 |
25,593 |
0 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • – |
2015-05-20 |
4 |
A |
$0.00 |
$30,000 |
I/I |
10,000,000 |
11,810,558 |
0 |
- |
|
| BIOC |
Biocept Inc |
Director |
– • – |
2015-03-16 |
4 |
B |
$8.76 |
$49,643 |
D/D |
5,667 |
17,294 |
2.39 |
- |
|
| BIOC |
Biocept Inc |
Director |
– • – |
2015-02-13 |
4 |
B |
$1.25 |
$15,000 |
I/I |
12,000 |
16,858 |
2.1 |
- |
|
| BIOC |
Biocept Inc |
Director |
– • – |
2014-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,858 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
